Yuqin Zhang
Zhongshan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Surgery versus no surgery in platinum-sensitive relapsed ovarian cancer: final overall survival analysis of the SOC-1 randomized phase 3 trial.
Journal: Nature medicine
Published: February 22, 2024
Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial.
Journal: The Lancet. Oncology
Published: October 10, 2020
Spontaneous arterial thrombosis in a patient with advanced ovarian clear cell cancer: a case report and literature review.
Journal: The Journal of international medical research
Published: June 03, 2020
Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept.
Journal: Journal of gynecologic oncology
Published: April 27, 2020
A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study.
Journal: Journal of gynecologic oncology
Published: March 01, 2020
Survival benefits of dose-dense early postoperative intraperitoneal chemotherapy in front-line therapy for advanced ovarian cancer: a randomised controlled study.
Journal: British journal of cancer
Published: April 03, 2019
Addition of intraperitoneal cisplatin and etoposide to first-line chemotherapy for advanced ovarian cancer: a randomised, phase 2 trial.
Journal: British journal of cancer
Published: September 06, 2017
An improved nerve-sparing radical hysterectomy technique for cervical cancer using the paravesico-vaginal space as a new surgical landmark.
Journal: Oncotarget
Published: April 11, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026